6. Parkinson disease Clinical trials / Disease details
Clinical trials : 2,307 / Drugs : 2,007 - (DrugBank : 349) / Drug target genes : 188 - Drug target pathways : 199
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04396873 (ClinicalTrials.gov) | August 17, 2021 | 20/5/2020 | PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease | Phase 1 Study: PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease | Dementia;Alzheimer's Disease;ALS;Parkinson's Disease | Drug: 11C-MC1;Drug: 11C-PS13;Drug: 18f-florbetaben | National Institute of Mental Health (NIMH) | NULL | Recruiting | 18 Years | 99 Years | All | 136 | Phase 1 | United States |